LFSC Holdings Information

LFSC is an equity ETF with a total of 40 individual holdings. The top holdings are Travere Therapeutics stock at 7.89%, Cogent Biosciences at 7.11%, LivaNova at 6.87%, Spyre Therapeutics at 6.44%, and Guardant Health at 6.10%.

Total Holdings

Top 10 Percentage

57.10%

Asset Class

Equity

ETF Category

Health

Assets

108.34M

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	TVTX	Travere Therapeutics, Inc.	7.89%	172,634
2	COGT	Cogent Biosciences, Inc.	7.11%	228,688
3	LIVN	LivaNova PLC	6.87%	102,350
4	SYRE	Spyre Therapeutics, Inc.	6.44%	92,618
5	GH	Guardant Health, Inc.	6.10%	45,197
6	CORT	Corcept Therapeutics Incorporated	5.31%	73,269
7	MIRM	Mirum Pharmaceuticals, Inc.	5.19%	51,483
8	CYTK	Cytokinetics, Incorporated	4.23%	60,891
9	BLLN	BillionToOne, Inc.	4.21%	43,600
10	MANE	Veradermics, Incorporated	3.75%	35,967
11	UTHR	United Therapeutics Corporation	3.54%	7,928
12	TRVI	Trevi Therapeutics, Inc.	3.37%	234,208
13	SVRA	Savara Inc.	3.29%	658,354
14	NKTR	Nektar Therapeutics	2.94%	51,448
15	DNTH	Dianthus Therapeutics, Inc.	2.67%	35,276
16	AXSM	Axsome Therapeutics, Inc.	2.52%	12,864
17	TMDX	TransMedics Group, Inc.	2.34%	42,364
18	VRDN	Viridian Therapeutics, Inc.	2.10%	134,761
19	PVLA	Palvella Therapeutics, Inc.	2.06%	17,446
20	CRVS	Corvus Pharmaceuticals, Inc.	2.04%	167,165
21	ICUI	ICU Medical, Inc.	2.04%	16,409
22	TWST	Twist Bioscience Corporation	1.44%	18,050
23	CBLL	CeriBell, Inc.	1.40%	89,348
24	HNGE	Hinge Health, Inc.	1.20%	17,787
25	BBIO	BridgeBio Pharma, Inc.	1.16%	18,741

Showing 25 of 40 holdings

Subscribe to see the full list

Activate Now

As of Jul 2, 2026